Percutaneous Coronary Intervention in Chronic Total Occlusions: Success Rates and Predictors
International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)
DOI: 10.25258/ijcpr.18.4.190 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von Manish Kumar und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Chronic total occlusions (CTOs) are considered among the most complex lesions encountered in interventional cardiology. Despite advances in techniques and devices, success rates vary widely depending on lesion and patient characteristics.
Objective
To evaluate the effectiveness of percutaneous coronary intervention (PCI) in chronic total occlusions and to determine independent predictors of procedural success.
Methods
This study included 100 patients undergoing CTO-PCI between 2019 and 2022. Clinical, angiographic, and procedural variables were recorded. Statistical analysis was performed to determine predictors of success.
Results
The overall procedural success rate was 78%. Factors significantly associated with success included shorter lesion length (
Zitieren
APA
Kumar, M., Kumari, P., Kumar, S., Thakur, R., & Pandey, U. (2026). Percutaneous Coronary Intervention in Chronic Total Occlusions: Success Rates and Predictors. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.190
Vancouver
Kumar M, Kumari P, Kumar S, Thakur R, Pandey U. Percutaneous Coronary Intervention in Chronic Total Occlusions: Success Rates and Predictors. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.190
BibTeX
@article{Kumar2026,
author = {Kumar, Manish and Kumari, Priyanka and Kumar, Santosh and Thakur, Ramesh and Pandey, Umeshwar},
title = {Percutaneous Coronary Intervention in Chronic Total Occlusions: Success Rates and Predictors},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {04},
doi = {10.25258/ijcpr.18.4.190}
}
EUVIMED